Exclusive: Actavis plans new merger approach for Allergan - sources

Actavis aims to head Valeant Pharmaceuticals off at the pass with a competing bid to acquire Allergan, people familiar with the matter tell Reuters.

Actavis, Pershing Square Capital Management, Salix Pharmaceuticals, Valeant Pharmaceuticals, Allergan Inc.

News Well, Mergers & Acquisitions, Pharmaceuticals, Wall Street Beat

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1tAyzIE